Warner-Chilcott Co. LLC, et al. v. Ranbaxy, Inc., et al.
(12-2474-FSH) (D. NJ) Patent litigation regarding Ranbaxy’s ANDA for Warner-Chilcott’s osteoporosis product Atelvia® (risedronate).
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.